{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:27:56Z","timestamp":1790893676706,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Individuals living with rare congenital malformations and\/or intellectual disability often face challenges in accessing appropriate healthcare. Clinical practice guidelines (CPGs) may serve as a tool to provide evidence-based care for rare diseases, but their development is complex, and the views of affected individuals and families often remain unknown.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Patient advocates of the European Reference Network ITHACA (Intellectual disability, TeleHealth, Autism and Congenital Anomalies) participated in focus groups in which their experiences with and perspectives on CPG use and development were discussed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Patient advocates considered CPGs relevant to address information and care needs and support advocacy efforts. Important characteristics included representation of heterogeneity within conditions, a holistic approach in which and how topics are addressed, user-friendly availability for individuals and families, and reliability of information. Guideline development and implementation were described as challenging, iterative processes in which effective partnership between clinicians, patient advocates, and other stakeholders is essential.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Understanding the perspectives of patient advocates is essential to develop CPGs that meet the life-long and complex care needs of individuals and families living with rare conditions. Identified challenges include balancing the urgency of information needs with thorough guideline development processes, as well as the integration and interpretation of different types of knowledge.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03673-9","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T23:18:01Z","timestamp":1744240681000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["\u2018We are the engine\u2019: a focus group study on clinical practice guideline development with European patient advocates for rare congenital malformations and\/or intellectual disability"],"prefix":"10.1186","volume":"20","author":[{"given":"Mirthe Jasmijn","family":"Klein Haneveld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chlo\u00e9 Aym\u00e9e","family":"de Mortier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Hugon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina Cornelia","family":"Cornel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte Maria Wilhelmina","family":"Gaasterland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8149-8645","authenticated-orcid":false,"given":"Agnies Marguerite","family":"van Eeghen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,10]]},"reference":[{"issue":"6","key":"3673_CR1","doi-asserted-by":"publisher","first-page":"4732","DOI":"10.3390\/ijerph20064732","volume":"20","author":"T Adachi","year":"2023","unstructured":"Adachi T, El-Hattab AW, Jain R, Nogales Crespo KA, Quirland Lazo CI, Scarpa M, et al. Enhancing equitable access to rare disease diagnosis and treatment around the world: a review of evidence, policies, and challenges. Int J Environ Res Public Health. 2023;20(6):4732. https:\/\/doi.org\/10.3390\/ijerph20064732.","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"3673_CR2","doi-asserted-by":"publisher","first-page":"296","DOI":"10.4415\/ANN_19_03_17","volume":"55","author":"A Montserrat","year":"2019","unstructured":"Montserrat A, Taruscio D. Policies and actions to tackle rare diseases at European level. Ann Ist Super Sanita. 2019;55(3):296\u2013304. https:\/\/doi.org\/10.4415\/ANN_19_03_17.","journal-title":"Ann Ist Super Sanita"},{"issue":"9","key":"3673_CR3","doi-asserted-by":"publisher","first-page":"e055428","DOI":"10.1136\/bmjopen-2021-055428","volume":"12","author":"EA Bryant","year":"2022","unstructured":"Bryant EA, Scott AM, Greenwood H, Thomas R. Patient and public involvement in the development of clinical practice guidelines: a scoping review. BMJ Open. 2022;12(9):e055428. https:\/\/doi.org\/10.1136\/bmjopen-2021-055428.","journal-title":"BMJ Open"},{"issue":"4","key":"3673_CR4","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.pec.2020.10.001","volume":"104","author":"C Kim","year":"2021","unstructured":"Kim C, Berta WB, Gagliardi AR. Exploring approaches to identify, incorporate and report patient preferences in clinical guidelines: qualitative interviews with guideline developers. Patient Educ Couns. 2021;104(4):703\u20138. https:\/\/doi.org\/10.1016\/j.pec.2020.10.001.","journal-title":"Patient Educ Couns"},{"issue":"5","key":"3673_CR5","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1111\/hex.12067","volume":"18","author":"HM van de Bovenkamp","year":"2015","unstructured":"van de Bovenkamp HM, Zuiderent-Jerak T. An empirical study of patient participation in guideline development: exploring the potential for articulating patient knowledge in evidence-based epistemic settings. Health Expect. 2015;18(5):942\u201355. https:\/\/doi.org\/10.1111\/hex.12067.","journal-title":"Health Expect"},{"issue":"1","key":"3673_CR6","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1186\/s12913-022-07736-6","volume":"22","author":"AM Biggane","year":"2022","unstructured":"Biggane AM, Young B, Williamson PR, Whittingham E, Cooper J. Enhancing patient and public contribution in health outcome selection during clinical guideline development: an ethnographic study. BMC Health Serv Res. 2022;22(1):361. https:\/\/doi.org\/10.1186\/s12913-022-07736-6.","journal-title":"BMC Health Serv Res"},{"key":"3673_CR7","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12913-016-1319-4","volume":"16","author":"N Fearns","year":"2016","unstructured":"Fearns N, Kelly J, Callaghan M, Graham K, Loudon K, Harbour R, et al. What do patients and the public know about clinical practice guidelines and what do they want from them? A qualitative study. BMC Health Serv Res. 2016;16:74. https:\/\/doi.org\/10.1186\/s12913-016-1319-4.","journal-title":"BMC Health Serv Res"},{"issue":"3","key":"3673_CR8","doi-asserted-by":"publisher","first-page":"e0174329","DOI":"10.1371\/journal.pone.0174329","volume":"12","author":"MJ Armstrong","year":"2017","unstructured":"Armstrong MJ, Mullins CD, Gronseth GS, Gagliardi AR. Recommendations for patient engagement in guideline development panels: a qualitative focus group study of guideline-naive patients. PLoS ONE. 2017;12(3):e0174329. https:\/\/doi.org\/10.1371\/journal.pone.0174329.","journal-title":"PLoS ONE"},{"issue":"1","key":"3673_CR9","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12911-019-0911-z","volume":"19","author":"A Babac","year":"2019","unstructured":"Babac A, von Friedrichs V, Litzkendorf S, Zeidler J, Damm K, Graf von der Schulenburg JM. Integrating patient perspectives in medical decision-making: a qualitative interview study examining potentials within the rare disease information exchange process in practice. BMC Med Inform Decis Mak. 2019;19(1):188. https:\/\/doi.org\/10.1186\/s12911-019-0911-z.","journal-title":"BMC Med Inform Decis Mak"},{"issue":"2\u20133","key":"3673_CR10","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.healthpol.2012.02.018","volume":"105","author":"K Budych","year":"2012","unstructured":"Budych K, Helms TM, Schultz C. How do patients with rare diseases experience the medical encounter? Exploring role behavior and its impact on patient-physician interaction. Health Policy. 2012;105(2\u20133):154\u201364. https:\/\/doi.org\/10.1016\/j.healthpol.2012.02.018.","journal-title":"Health Policy"},{"issue":"2","key":"3673_CR11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77\u2013101.","journal-title":"Qual Res Psychol"},{"key":"3673_CR12","unstructured":"VERBI Software. MAXQDA 2022. Berlin: VERBI Software; 2021."},{"issue":"4","key":"3673_CR13","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1007\/s11135-017-0574-8","volume":"52","author":"B Saunders","year":"2018","unstructured":"Saunders B, Sim J, Kingstone T, Baker S, Waterfield J, Bartlam B, et al. Saturation in qualitative research: exploring its conceptualization and operationalization. Qual Quant. 2018;52(4):1893\u2013907. https:\/\/doi.org\/10.1007\/s11135-017-0574-8.","journal-title":"Qual Quant"},{"issue":"6","key":"3673_CR14","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349\u201357. https:\/\/doi.org\/10.1093\/intqhc\/mzm042.","journal-title":"Int J Qual Health Care"},{"issue":"3","key":"3673_CR15","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1177\/17446295211002348","volume":"26","author":"MK Tschamper","year":"2022","unstructured":"Tschamper MK, Systad S. Rare, epilepsy-related disorder including intellectual disability: a scoping review of caregivers\u2019 identified information needs. J Intellect Disabil. 2022;26(3):704\u201317. https:\/\/doi.org\/10.1177\/17446295211002348.","journal-title":"J Intellect Disabil"},{"issue":"1","key":"3673_CR16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13023-017-0755-5","volume":"13","author":"D Whicher","year":"2018","unstructured":"Whicher D, Philbin S, Aronson N. An overview of the impact of rare disease characteristics on research methodology. Orphanet J Rare Dis. 2018;13(1):14. https:\/\/doi.org\/10.1186\/s13023-017-0755-5.","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"3673_CR17","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1007\/s10803-019-03973-7","volume":"50","author":"MC Van Remmerden","year":"2020","unstructured":"Van Remmerden MC, Hoogland L, Mous SE, et al. Growing up with fragile X syndrome: concerns and care needs of young adult patients and their parents. J Autism Dev Disord. 2020;50(6):2174\u201387. https:\/\/doi.org\/10.1007\/s10803-019-03973-7.","journal-title":"J Autism Dev Disord"},{"key":"3673_CR18","unstructured":"World Health Organization (WHO). International classification of functioning, disability and health (ICF). Geneva: World Health Organization; 2001. https:\/\/apps.who.int\/iris\/handle\/10665\/42407"},{"key":"3673_CR19","doi-asserted-by":"publisher","DOI":"10.1093\/acprof:oso\/9780198237907.001.0001","volume-title":"Epistemic injustice: power and the ethics of knowing","author":"M Fricker","year":"2007","unstructured":"Fricker M. Epistemic injustice: power and the ethics of knowing. Oxford: Oxford University Press; 2007."},{"key":"3673_CR20","doi-asserted-by":"publisher","first-page":"113702","DOI":"10.1016\/j.socscimed.2021.113702","volume":"272","author":"S Wieringa","year":"2021","unstructured":"Wieringa S, Engebretsen E, Heggen K, Greenhalgh T. Clinical guidelines and the pursuit of reducing epistemic uncertainty: an ethnographic study of guideline development panels in three countries. Soc Sci Med. 2021;272:113702. https:\/\/doi.org\/10.1016\/j.socscimed.2021.113702.","journal-title":"Soc Sci Med"},{"issue":"1","key":"3673_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/hex.12467","volume":"20","author":"MJ Armstrong","year":"2017","unstructured":"Armstrong MJ, Rueda JD, Gronseth GS, Mullins CD. Framework for enhancing clinical practice guidelines through continuous patient engagement. Health Expect. 2017;20(1):3\u201310. https:\/\/doi.org\/10.1111\/hex.12467.","journal-title":"Health Expect"},{"key":"3673_CR22","unstructured":"EURORDIS-Rare Diseases Europe. Guide for patient involvement in the development of clinical practice guidelines & clinical decision support tools. 2022."},{"issue":"2","key":"3673_CR23","doi-asserted-by":"publisher","first-page":"lyac008","DOI":"10.1093\/ijcoms\/lyac008","volume":"2","author":"R Sipil\u00e4","year":"2022","unstructured":"Sipil\u00e4 R, H\u00e4meen-Anttila K, Komulainen J. Patient representatives need various methods to be involved in clinical practice guidelines: a qualitative study in Finland. IJQHC Commun. 2022;2(2):lyac008. https:\/\/doi.org\/10.1093\/ijcoms\/lyac008.","journal-title":"IJQHC Commun"},{"issue":"13","key":"3673_CR24","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1177\/1049732315617444","volume":"26","author":"K Malterud","year":"2016","unstructured":"Malterud K, Siersma VD, Guassora AD. Sample size in qualitative interview studies: guided by information power. Qual Health Res. 2016;26(13):1753\u201360. https:\/\/doi.org\/10.1177\/1049732315617444.","journal-title":"Qual Health Res"},{"issue":"1","key":"3673_CR25","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1186\/s13023-022-02522-3","volume":"17","author":"AA Dwyer","year":"2022","unstructured":"Dwyer AA, Uveges M, Dockray S, Smith N. Advancing qualitative rare disease research methodology: a comparison of virtual and in-person focus group formats. Orphanet J Rare Dis. 2022;17(1):354. https:\/\/doi.org\/10.1186\/s13023-022-02522-3.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"3673_CR26","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s40271-019-00390-x","volume":"13","author":"J Karpusheff","year":"2020","unstructured":"Karpusheff J, Haynes C, Glen F, Leng G. Involving people with learning disabilities in guideline development. Patient. 2020;13(2):251\u20134. https:\/\/doi.org\/10.1007\/s40271-019-00390-x.","journal-title":"Patient"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03673-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03673-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03673-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T13:08:24Z","timestamp":1744290504000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03673-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3673"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03673-9","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,10]]},"assertion":[{"value":"20 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"On 8 December 2022, the Medical Ethics Review Committee AMC declared that the Dutch Medical Research Involving Human Subjects Act (WMO) does not apply to this study and that official ethical approval is not required. All participants provided oral informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"169"}}